FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 166 of 166

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
TEVA New York Teva Pharmaceutical Industries Limited 2834
THAR Nasdaq Tharimmune, Inc. 2834
TLPH Nasdaq Talphera, Inc. 2834
TLSA Nasdaq Tiziana Life Sciences Ltd 2834
TNGX Nasdaq Tango Therapeutics, Inc. 2834
TOVX NYSE American Theriva Biologics, Inc. 2834
TRAW Nasdaq Traws Pharma, Inc. 2834
TRDA Nasdaq Entrada Therapeutics, Inc. 2834
TRVI Nasdaq Trevi Therapeutics, Inc. 2834
TXMD Nasdaq TherapeuticsMD, Inc. 2834
VIR Nasdaq Vir Biotechnology, Inc. 2834
VNDA Nasdaq Vanda Pharmaceuticals Inc. 2834
VRCA Nasdaq Verrica Pharmaceuticals Inc. 2834
VYGR Nasdaq Voyager Therapeutics, Inc. 2834
YCBD NYSE American cbdMD, Inc. 2834
ZVRA Nasdaq Zevra Therapeutics, Inc. 2834
Results 150 through 166 of 166